CClinicalTrials.gg
CompletedNCT05184608Updated May 25, 2022

Cycling Dual-task in Parkinson's Disease

An interventional study of Cycling exercise and Cognitive tasks in Parkinson Disease, sponsored by University of Vigo. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2022-05-25.

Sponsored by University of Vigo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Sex
All
01

Study summary

Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.

02

Conditions studied

  • Parkinson Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 15 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Vigo is the lead sponsor of 53 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Parkinson disease
  • Hoehn and Yahr 1 and 2

Exclusion criteria

Exclusion Criteria:

  • Hoehn and Yahr >2
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Cycling combined with cognitive tasks

    Other: Cycling exercise · Other: Cognitive tasks

  • Active comparator
    Cycling

    Other: Cycling exercise

Interventions

  • OtherCycling exercise

    20 minutes of cycling (90 rpm).

  • OtherCognitive tasks

    20 minutes of cognitive tasks based on the different domains of the UPDRS scale.

06

What researchers measure

Primary outcomes

  1. Timed Up and Go

    Dynamic balance

    Time frame: Change from Baseline Timed Up and Go at 7 weeks

  2. Sit to Stand test

    Lower limbs strength

    Time frame: Change from Baseline Sit to Stan Test at 7 weeks

  3. Movement Disorder Society - Unified Parkinson's Disease Rating Scale

    Parkinson's Disease rating

    Time frame: Change from Baseline Unified Parkinson's Disease Rating Scale at 7 weeks (0-159, better lower values)

  4. Parkinson's Disease Questionnaire - 39

    Quality of life

    Time frame: Change from Baseline Parkinson's Disease Questionnaire - 39 at 7 weeks (0-100, better lower values)

Secondary outcomes

  1. Trail Making Test A & B

    Attention, visual screening ability and processing speed

    Time frame: Change from Baseline Trail Making Test A & B at 7 weeks

  2. Stroop test

    Ability to inhibit cognitive interference

    Time frame: Change from Baseline Stroop Test at 7 weeks

07

Study locations

1 site
  • University of Vigo
    Pontevedra, 36004, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05184608
Lead sponsor
University of Vigo
Responsible party
Iris Machado de Oliveira (Principal Investigator, University of Vigo) — Principal investigator
First posted
Jan 11, 2022
Start date
Oct 11, 2021
Primary completion
Oct 28, 2021
Completion
Jan 31, 2022
Last update
May 25, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion